0001384101-23-000132.txt : 20230719
0001384101-23-000132.hdr.sgml : 20230719
20230719203544
ACCESSION NUMBER: 0001384101-23-000132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISHOP JOHN L
CENTRAL INDEX KEY: 0001189846
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 231097924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wk-form4_1689813334.xml
FORM 4
X0508
4
2023-07-17
0
0001384101
VERACYTE, INC.
VCYT
0001189846
BISHOP JOHN L
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
1
Common Stock
2023-07-17
4
M
0
10000
6.37
A
43125
D
Common Stock
2023-07-17
4
S
0
10000
30.0002
D
33125
D
Common Stock
2023-07-18
4
M
0
10000
6.37
A
43125
D
Common Stock
2023-07-18
4
S
0
10000
30.50
D
33125
D
Stock Option (right to buy)
6.37
2023-07-17
4
M
0
10000
0
D
2024-12-01
Common Stock
10000
25000
D
Stock Option (right to buy)
6.37
2023-07-18
4
M
0
10000
0
D
2024-12-01
Common Stock
10000
15000
D
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023.
Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The option is fully vested.
/s/ Jonathan Wygant, as attorney-in-fact
2023-07-19